Category: Post-doctoral fellow

Irish GPs support wider use of naloxone to treat opiate addiction

Two thirds of GPs in Ireland support planned initiatives to provide wider availability of naloxone in the community for treating opiate addiction and overdose, a survey by University College Ireland has found.1
More than 200 deaths due to opiate overdose occur each year in Ireland, one of the highest rates in Europe. Naloxone is an effective opiate antagonist that can revert opiate overdose. “Take home” naloxone schemes, in which patients considered at risk …

by Susan Mayor
BMJ 2017356 doi: https://doi.org/10.1136/bmj.j1103 (Published 03 March 2017)Cite this as: BMJ 2017;356:j1103 

Off the record: addictions in medical schools

If it’s not recorded, it didn’t happen.
An old saying
We wanted to find out how much teaching on addiction get on medical students. In 2011, our colleagues Sarah O’Brien and Professor Cullen searched PubMed (online database of medical papers) for published literature on training of undergraduate medical students in addiction
There is currently no documentation of drug addiction teaching sessions in Irish medical schools.
photocredit: mrmediatraining.com
We looked at other medical databases and we also searched websites of all 6 medical schools in Ireland.  We have searched the literature published after October 2009.
We found nothing in the medical databases. Schools’ homepages did not mention addiction either.
A telephone survey may provide a more accurate representation of how addiction medicine education is incorporated into the medical school curricula.
  
Substance use disorders are a worldwide problem, and have become a major health concern in Ireland particularly.
In their new position paper on addiction, the Irish Medical Organisation recognized the lacking education and called for “appropriate training of all physicians in treatment of addiction” (Irish Medical Organisation, 2015). Although the science behind addiction treatment has discovered new treatments for addiction, the medical doctors don’t know about them, mainly because they get no training on addiction. As a result, they feel unprepared to treat people with addiction who receive inadequate care.

To cite this article: Mitch Wilson, Walter Cullen, Christine Goodair & Jan Klimas (2016): Off the record: Substance-related disorders in the undergraduate medical curricula in IrelandJournal of Substance Use, DOI: 10.3109/14659891.2015.1112853

Primary care looks at drinking among persons on methadone treatment

How should primary care doctors ask their methadone patients about alcohol use?

We worked with 13 primary care doctors and divided them into two groups. We trained one group on how to ask about and advise on heavy drinking. We looked at whether trained and coached doctors managed patients who drank.
photocredit: methadoneaddiction.com


Primary care can look at drinking among persons on methadone treatment and advise on risks of heavy drinking.

We found that the trained doctors asked about and advised on heavy drinking more often than the untrained doctors. Four patients in their care drank less alcohol three months later, compared to two patients of the untrained doctors. Some doctors were reluctant to use their new learning in the practice because it was too complicated.

A bigger and simpler study must prove the positive results of this modest study

Methadone helps people with opioid use disorders use less drugs, but it doesn’t stop them from drinking. About 30% of them drink in excess of the low-risk drinking limits. Drinking makes their treatment harder and their health worse. Primary care doctors who prescribe methadone see patients weekly and can help them drink less.

Reference: Henihan, AM., McCombe, G., Klimas, J., Swan, D., Leahy, D….Cullen, W. (2016)  Feasibility of Alcohol Screening among Patients receiving Opioid Agonist Treatment in Primary Care. BMC Family Practice, 17:153




Hepatitis C unchanged, but drinking soared

NEW PAPER OUT NOW 

What is the study about?

           We wanted to find out how many people receiving treatment for opioid addiction (methadone) have Hepatitis C and other blood borne viruses
           And whether anything changed between the years 2006 and 2013

QUICK FACT:

Over a third of people who receive methadone in primary care and who drink excessively test positive for Hepatitis C
 

asam.org

How was the study done?

           In 2013, we have done a secondary analysis of data collected during a feasibility study of an alcohol brief intervention for people attending primary care for methadone treatment
           We looked at two studies done in 2006 and 2013 and compared them

What did the study find?

           We found the proportion of patients with problem alcohol use was much higher (46% v 35%) in 2013.
           37% of people who had Hepatitis C also drank excessively
In 2013, number of people who had Hepatitis C was not different from 2006, but more people drank excessively.

Why is the study important?

           Many people who receive treatment for opioid addiction have Hepatitis C
           Treatment of Hepatitis C is expensive
           Because heavy drinking can make the treatment even more expensive, we should help people drink less
Reference: Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention. Journal of Addiction Medicine: September/October 2016 – Volume 10 – Issue 5 – p 363–364
(http://journals.lww.com/journaladdictionmedicine/Citation/2016/10000/Commentary_on_Zeremski_et_al___2016___.11.aspx)